MAP3K13 Antikörper (Center)
Kurzübersicht für MAP3K13 Antikörper (Center) (ABIN5620099)
Target
Alle MAP3K13 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- Center
-
Spezifität
- Recognizes endogenous levels of LZK protein
-
Kreuzreaktivität (Details)
- Mouse, Rat, Bovine, Chicken, Dog, Rabbit
-
Produktmerkmale
- Purified Polyclonal LZK antibody
-
Aufreinigung
- LZK antibody was purified by immunogen affinity chromatography
-
Immunogen
- LZK antibody was raised in Rabbit using a KLH-conjugated synthetic peptide encompassing a sequence within the center region of human LZK as the immunogen
-
-
-
-
Applikationshinweise
- WB: 1:500 - 1:1000, IP: 1:10 - 1:100
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Supplied in liquid form in 0.42 % Potassium phosphate, 0.87 % Sodium chloride, pH 7.3 with 30 % glycerol and 0.01 % sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 4 deg C for short term storage. For long term, aliquot and store at -20 deg C. Avoid repeat freeze/thaw cycles
-
-
- MAP3K13 (Mitogen-Activated Protein Kinase Kinase Kinase 13 (MAP3K13))
-
Andere Bezeichnung
- LZK
-
Pathways
- Signaling Events mediated by VEGFR1 and VEGFR2
Target
-